STAT+: Pharmalittle: We’re reading about a fugitive who became a biotech exec, a hospital suing Lilly, and more

MAP Verified Summary — reported by STAT News

The discovery that a fugitive had been working under an alias in the biotech industry prompted a question: How did he evade scrutiny for two decades?

This story was scored across MAP’s five-signal verification framework — Context, Presentation, References, Visibility, and Comparison — as part of Media Alert Press’s independent media credibility index. Read the full original story at STAT News →